当前位置:首页 - 行情中心 - 恩华药业(002262) - 财务分析

恩华药业

(002262)

  

流通市值:205.27亿  总市值:234.57亿
流通股本:8.82亿   总股本:10.08亿

恩华药业(002262)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润2.65亿元,每股收益0.26元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益667474.64万元,未分配利润507830.14万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产760395.48万元,负债92920.84万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入1,357,565,651.125,041,504,467.273,655,985,179.262,400,328,791.85
营业总成本1,036,808,322.123,912,018,753.632,660,054,429.071,774,122,216.02
营业利润304,871,280.841,182,344,167.981,005,456,875.82626,092,044.42
利润总额299,736,147.11,168,644,097.611,000,774,839.69621,989,781.31
净利润264,638,776.411,034,247,287.51883,414,665.34544,408,392.98
其他综合收益--6,348,894.4--
综合收益总额264,638,776.411,027,898,393.11883,414,665.34544,408,392.98
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计5,472,389,079.645,254,561,353.735,163,192,482.594,884,439,434.77
非流动资产合计2,131,565,736.522,073,634,014.941,975,972,727.721,946,203,539
资产总计7,603,954,816.167,328,195,368.677,139,165,210.316,830,642,973.77
流动负债合计823,477,079.03814,027,830.97792,340,808.33809,496,809.68
非流动负债合计105,731,295.34104,059,872.3280,171,209.7693,499,244.23
负债合计929,208,374.37918,087,703.29872,512,018.09902,996,053.91
归属于母公司股东权益合计6,699,423,735.516,434,141,487.486,306,372,313.45,965,434,019.97
股东权益合计6,674,746,441.796,410,107,665.386,266,653,192.225,927,646,919.86
负债和股东权益合计7,603,954,816.167,328,195,368.677,139,165,210.316,830,642,973.77
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计1,466,400,764.715,391,489,025.364,055,730,072.312,633,879,665.86
经营活动现金流出小计1,232,818,489.414,383,188,978.943,237,081,292.642,188,135,214.89
经营活动产生的现金流量净额233,582,275.31,008,300,046.42818,648,779.67445,744,450.97
投资活动现金流入小计1,011,725,654.776,534,228,226.384,800,950,332.33,981,980,124.23
投资活动现金流出小计1,685,247,521.296,827,619,141.174,868,778,850.413,787,287,578.06
投资活动产生的现金流量净额-673,521,866.52-293,390,914.79-67,828,518.11194,692,546.17
筹资活动现金流入小计20,000,00080,000,00040,000,00025,000,000
筹资活动现金流出小计18,049,004.82290,173,686.57266,555,716.9240,531,059.55
筹资活动产生的现金流量净额1,950,995.18-210,173,686.57-226,555,716.9-215,531,059.55
汇率变动对现金及现金等价物的影响129,752.08414,761.9128,999.3526,960.96
现金及现金等价物净增加额-437,858,843.96505,150,206.97524,293,544.01424,932,898.55
期末现金及现金等价物余额1,571,753,981.332,009,612,825.292,026,653,961.981,929,395,516.87
最新报告期:2024-04-12
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
华泰证券代雯,李奕玮1.241.511.882024-04-12
浙商证券孙建,郭双喜1.241.481.752024-04-10
广发证券李安飞,罗佳荣1.211.441.712024-04-06
中金公司张琎,朱言音,杨一正1.251.49--2024-04-02
中信建投证券袁清慧,贺菊颖1.241.501.832024-04-02
TOP↑